Literature DB >> 22343184

Protective effect of an elastase inhibitor in a neuromyelitis optica-like disease driven by a peptide of myelin oligodendroglial glycoprotein.

Katja Herges1, Brigit A de Jong, Ilan Kolkowitz, Caitlin Dunn, Gil Mandelbaum, Rose M Ko, Alexander Maini, May H Han, Joep Killestein, Chris Polman, Alexandra L Goodyear, Jeffrey Dunn, Lawrence Steinman, Robert C Axtell.   

Abstract

BACKGROUND: The pathology of neuromyelitis optica (NMO), in contrast to multiple sclerosis, comprises granulocyte infiltrates along extensive lengths of spinal cord, as well as optic nerve. Furthermore, IFN-β treatment worsens NMO. We recently found that experimental autoimmune encephalomyelitis (EAE) induced with Th17 cells is exacerbated by IFN-β, in contrast to disease induced with Th1 where treatment attenuated symptoms.
OBJECTIVE: This study demonstrates the similarities between NMO and Th17 EAE and how neutrophils mediate pathology in Th17 disease.
METHODS: Levels of blood biomarkers in NMO were assessed by Luminex and ELISA. Effects of IFN-β on neutrophils were assessed by culture assays and immunofluorescence. EAE was induced by transfer of myelin-specific Th1 or Th17 cells and treated with Sivelestat sodium hydrate, a neutrophil elastase inhibitor.
RESULTS: We show Th17 cytokines, granulocyte chemokines, type 1 interferon and neutrophil elastase are elevated in patients with definitive NMO. In culture, we find that IFN-β stimulates neutrophils to release neutrophil elastase. In Th17 EAE, we demonstrate neutrophilic infiltration in the optic nerve and spinal cord which was not present in Th1 EAE. Blockade of neutrophil elastase with Sivelestat had efficacy in Th17 EAE but not Th1 EAE.
CONCLUSIONS: The similarities between Th17 EAE and NMO indicate that this model represents several aspects of NMO. Neutrophils are critical in the pathologies of both Th17-EAE and NMO, and therefore blockade of neutrophil elastase is a promising target in treating NMO.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22343184      PMCID: PMC3319834          DOI: 10.1177/1352458512440060

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  34 in total

1.  Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis.

Authors:  M Tintoré; A Rovira; M J Martínez; J Rio; P Díaz-Villoslada; L Brieva; C Borrás; E Grivé; J Capellades; X Montalban
Journal:  AJNR Am J Neuroradiol       Date:  2000-04       Impact factor: 3.825

2.  Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG.

Authors:  I Nakashima; K Fujihara; I Miyazawa; T Misu; K Narikawa; M Nakamura; S Watanabe; T Takahashi; S Nishiyama; Y Shiga; S Sato; B G Weinshenker; Y Itoyama
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-02-27       Impact factor: 10.154

3.  Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells.

Authors:  Ingunn M Stromnes; Lauren M Cerretti; Denny Liggitt; Robert A Harris; Joan M Goverman
Journal:  Nat Med       Date:  2008-02-17       Impact factor: 53.440

4.  Neutrophils produce interleukin 17A (IL-17A) in a dectin-1- and IL-23-dependent manner during invasive fungal infection.

Authors:  Jessica L Werner; Melissa A Gessner; Lauren M Lilly; Michael P Nelson; Allison E Metz; Dawn Horn; Chad W Dunaway; Jessy Deshane; David D Chaplin; Casey T Weaver; Gordon D Brown; Chad Steele
Journal:  Infect Immun       Date:  2011-08-01       Impact factor: 3.441

5.  Interleukin-17-secreting T cells in neuromyelitis optica and multiple sclerosis during relapse.

Authors:  H H Wang; Y Q Dai; W Qiu; Z Q Lu; F H Peng; Y G Wang; J Bao; Y Li; X Q Hu
Journal:  J Clin Neurosci       Date:  2011-07-26       Impact factor: 1.961

6.  Interferon beta-1b exacerbates multiple sclerosis with severe optic nerve and spinal cord demyelination.

Authors:  Yoko Warabi; Yoh Matsumoto; Hideaki Hayashi
Journal:  J Neurol Sci       Date:  2006-11-27       Impact factor: 3.181

7.  An IL-17F/A heterodimer protein is produced by mouse Th17 cells and induces airway neutrophil recruitment.

Authors:  Spencer C Liang; Andrew J Long; Frann Bennett; Matthew J Whitters; Riyez Karim; Mary Collins; Samuel J Goldman; Kyriaki Dunussi-Joannopoulos; Cara M M Williams; Jill F Wright; Lynette A Fouser
Journal:  J Immunol       Date:  2007-12-01       Impact factor: 5.422

8.  A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica.

Authors:  Claudia F Lucchinetti; Raul N Mandler; Dorian McGavern; Wolfgang Bruck; Gerald Gleich; Richard M Ransohoff; Corinna Trebst; Brian Weinshenker; Dean Wingerchuk; Joseph E Parisi; Hans Lassmann
Journal:  Brain       Date:  2002-07       Impact factor: 13.501

9.  Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica.

Authors:  Friedemann Paul; Sven Jarius; Orhan Aktas; Martin Bluthner; Oliver Bauer; Heribert Appelhans; Diego Franciotta; Roberto Bergamaschi; Edward Littleton; Jacqueline Palace; Hans-Peter Seelig; Reinhard Hohlfeld; Angela Vincent; Frauke Zipp
Journal:  PLoS Med       Date:  2007-04       Impact factor: 11.069

10.  Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis.

Authors:  John S Tzartos; Manuel A Friese; Matthew J Craner; Jackie Palace; Jia Newcombe; Margaret M Esiri; Lars Fugger
Journal:  Am J Pathol       Date:  2007-12-21       Impact factor: 4.307

View more
  37 in total

Review 1.  Aquaporin 4 and neuromyelitis optica.

Authors:  Marios C Papadopoulos; A S Verkman
Journal:  Lancet Neurol       Date:  2012-05-16       Impact factor: 44.182

2.  Optic neuritis in neuromyelitis optica.

Authors:  Marc H Levin; Jeffrey L Bennett; A S Verkman
Journal:  Prog Retin Eye Res       Date:  2013-03-30       Impact factor: 21.198

3.  Treatment of Neuromyelitis Optica: Review and Recommendations.

Authors:  Dorlan J Kimbrough; Kazuo Fujihara; Anu Jacob; Marco A Lana-Peixoto; Maria Isabel Leite; Michael Levy; Romain Marignier; Ichiro Nakashima; Jacqueline Palace; Jérôme de Seze; Olaf Stuve; Silvia N Tenembaum; Anthony Traboulsee; Emmanuelle Waubant; Brian G Weinshenker; Dean M Wingerchuk
Journal:  Mult Scler Relat Disord       Date:  2012-10       Impact factor: 4.339

4.  DNA threads released by activated CD4+ T lymphocytes provide autocrine costimulation.

Authors:  Massimo Costanza; Pietro L Poliani; Paola Portararo; Barbara Cappetti; Silvia Musio; Francesca Pagani; Lawrence Steinman; Mario P Colombo; Rosetta Pedotti; Sabina Sangaletti
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-15       Impact factor: 11.205

Review 5.  Neuromyelitis Optica: Deciphering a Complex Immune-Mediated Astrocytopathy.

Authors:  Jeffrey L Bennett; Gregory P Owens
Journal:  J Neuroophthalmol       Date:  2017-09       Impact factor: 3.042

6.  Review of Animal Models of Neuromyelitis Optica.

Authors:  Melina V Jones; Nicolas Collongues; Jerome de Seze; Makoto Kinoshita; Yuji Nakatsuji; Michael Levy
Journal:  Mult Scler Relat Disord       Date:  2012-10       Impact factor: 4.339

7.  Tolerance checkpoint bypass permits emergence of pathogenic T cells to neuromyelitis optica autoantigen aquaporin-4.

Authors:  Sharon A Sagan; Ryan C Winger; Andrés Cruz-Herranz; Patricia A Nelson; Sarah Hagberg; Corey N Miller; Collin M Spencer; Peggy P Ho; Jeffrey L Bennett; Michael Levy; Marc H Levin; Alan S Verkman; Lawrence Steinman; Ari J Green; Mark S Anderson; Raymond A Sobel; Scott S Zamvil
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-08       Impact factor: 11.205

8.  Serum autoantibodies to myelin peptides distinguish acute disseminated encephalomyelitis from relapsing-remitting multiple sclerosis.

Authors:  Keith Van Haren; Beren H Tomooka; Brian A Kidd; Brenda Banwell; Amit Bar-Or; Tanuja Chitnis; Silvia N Tenembaum; Daniela Pohl; Kevin Rostasy; Russell C Dale; Kevin C O'Connor; David A Hafler; Lawrence Steinman; William H Robinson
Journal:  Mult Scler       Date:  2013-04-23       Impact factor: 6.312

Review 9.  Present and Future Therapies in Neuromyelitis Optica Spectrum Disorders.

Authors:  Ingo Kleiter; Ralf Gold
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

Review 10.  B cells in autoimmune and neurodegenerative central nervous system diseases.

Authors:  Joseph J Sabatino; Anne-Katrin Pröbstel; Scott S Zamvil
Journal:  Nat Rev Neurosci       Date:  2019-11-11       Impact factor: 34.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.